bluebird bio is a biotechnology company engaged in researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases and cancer. The company has built a product platform with a range of therapeutic potential in a variety of indications based on its lentiviral gene addition platform, gene editing and cancer immunotherapy capabilities. The company is developing LentiGlobin gene therapy for sickle cell disease; Lenti-D gene therapy for cerebral adrenoleukodystrophy; and in collaboration with Bristol-Myers Squibb, the company is developing bb2121 (idecabtagene vicleucel) and bb21217 product candidates as treatments for multiple myeloma.

CommScope Holding is a provider of infrastructure solutions for communication networks. The company's solutions and services for wired and wireless networks enable high-bandwidth data, video and voice applications. The company's operating segments are: CommScope Connectivity Solutions (CCS) and CommScope Mobility Solutions (CMS). The CCS segment is engaged in providing fiber optic and copper connectivity solutions for use in data centers and business enterprise, telecommunications, cable television and residential broadband networks. The CMS segment is engaged in providing infrastructure for wireless networks.

GEO Group is a real estate investment trust focusing on the ownership, leasing and management of secure facilities, processing centers and reentry facilities and the provision of community-based services and youth services. The company owns, leases and operates a range of secure facilities including maximum, medium and minimum security facilities, processing centers, as well as community-based reentry facilities. The company provides compliance technologies, monitoring services, and evidence-based supervision and treatment programs for community-based parolees, probationers and pretrial defendants. The company also provides transportation services for offender and detainee populations as contracted.

Palomar is a holding company. Through its subsidiaries, the company provides specialty property insurance. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, specialty homeowners, commercial all-risk, hawaii hurricane, residential flood, and real estate investor.

Rhythm Pharmaceuticals is a biopharmaceutical company. The company's primary product candidate is setmelanotide, which is a melanocortin-4 (MC4) receptor agonist peptide for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. MC4 pathway deficiencies result in the disruption of satiety signals and energy homeostasis in the body, which, in turn, leads to intense feelings of hunger and to obesity. The company is evaluating setmelanotide for the treatment of six single gene related MC4 pathway deficiencies: pro-opiomelanocortin (POMC), leptin receptor, Bardet-Biedl syndrome, Alstrom syndrome, POMC heterozygous, and POMC epigenetic disorders.

Scholastic is a publisher and distributor of children's books, a provider of print and digital instructional materials for pre-kindergarten to grade 12, and a producer of educational and entertaining children's media. The company creates books and ebooks, print and technology-based learning materials and programs, classroom magazines and other products that, in combination, provides schools, as well as parents and children, solutions to support children's learning and reading both at school and at home. The company is the operator of school-based book clubs and book fair proprietary channels. It distributes its products and services through these channels, as well as directly to schools and libraries.